Questioned arthritis paper pulled

A journal retracted a linkurl:2004 paper;http://www.ncbi.nlm.nih.gov/pubmed/15301984?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum this week that was among the 70,000 papers linkurl:flagged last week;http://www.the-scientist.com/blog/display/54210/ as potentially containing plagiarized material. Last week's report, published in Nature, presented findings from a new text-search program that scanned medical literature for duplicate publication. The retrac

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A journal retracted a linkurl:2004 paper;http://www.ncbi.nlm.nih.gov/pubmed/15301984?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum this week that was among the 70,000 papers linkurl:flagged last week;http://www.the-scientist.com/blog/display/54210/ as potentially containing plagiarized material. Last week's report, published in Nature, presented findings from a new text-search program that scanned medical literature for duplicate publication. The retracted paper was one of 70 that the researchers noted as highly suspicious. The journal Best Practices & Research: Clinical Rheumatology, said in a statement to the Boston Globe that linkurl:it had retracted;http://www.boston.com/news/health/blog/2008/01/british_journal_1.html a 2004 paper by Lee S. Simon that reviewed treatments for rheumatoid arthritis, which contained text from a linkurl:2003 article;http://www.ncbi.nlm.nih.gov/pubmed/12904092?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum in Expert Opinion: Drug Safety by Roy Fleischmann at the University of Texas Southwestern Medical Center at Dallas. Simon declined to comment to the Globe, and spokespeople for Harvard Medical School and Beth Israel Deaconess Medical Center, where Simon is based, said they were investigating. According to the Chronicle of Higher Education, the authors of the Nature report linkurl:contacted the journals;http://chronicle.com/news/article/3835/journal-retracts-paper-flagged-by-search-tool and authors of the 70 papers they believed were highly suspect, and the retraction "appears to be the first result of their sleuthing."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alison McCook

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution